Status:
COMPLETED
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Lead Sponsor:
G & W Laboratories Inc.
Collaborating Sponsors:
Alquest
SMART Biotech Ltd
Conditions:
Human Immunodeficiency Virus Infection
Hepatitis C
Eligibility:
All Genders
18-64 years
Brief Summary
The purpose of this study is to compare the results for HIV and/or Hepatitis C Virus antibody testing when using routine plasma versus SMARTplasma from the same blood sample. SMARTplasma is enriched f...
Detailed Description
Following exposure to HIV and HCV, there is a "window period" where a person is infected with the virus but does not produce antibodies at a high enough level so they can be detected by antibody detec...
Eligibility Criteria
Inclusion
- Adults ages 18-64,
- Are not pregnant
- Not have a life-threatening disease
- Not immunosuppressed (HIV therapy allowed)
- Are able to give consent, and (6) who appear healthy.
Exclusion
- Do not meet the inclusion criteria
- Are enrolled in an HIV vaccine study,
- Who have previously been enrolled in this study
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT01447680
Start Date
August 1 2011
End Date
December 1 2012
Last Update
September 7 2015
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Therafirst Medical Centers
Fort Lauderdale, Florida, United States, 33308
2
American Red Cross
Douglasville, Georgia, United States, 30135
3
Evelyn Jordan Center
Baltimore, Maryland, United States, 21201
4
University of Maryland, School of Medicine
Baltimore, Maryland, United States, 21201